Adicet Bio, Inc. (ACET) income statement
ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$2.50−0.28 (-10.07%)
Close on Nov 18, 2026Market cap $23.40MP/E –Yield –
Adicet Bio, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -67.6%
Financial strength
- Current ratio
- 6.71
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 184.1%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.19
- Dividend yield
- –
See a number that looks wrong?